{"id":"https://openalex.org/W2208102967","doi":"https://doi.org/10.2174/1381612822666151215102420","title":"The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders","display_name":"The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders","alternate_titles":[],"publication_year":2015,"publication_date":"2015-12-15","ids":{"openalex":"https://openalex.org/W2208102967","doi":"https://doi.org/10.2174/1381612822666151215102420","mag":"2208102967","pmid":"https://pubmed.ncbi.nlm.nih.gov/26667000"},"language":"en","primary_location":{"id":"doi:10.2174/1381612822666151215102420","doi":"https://doi.org/10.2174/1381612822666151215102420","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612822666151215102420","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2208102967"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/The_many_neuroprogressive_actions_of_tryptophan_catabolites_TRYCATs_that_may_be_associated_with_the_pathophysiology_of_neuro-immune_disorders/20892640","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029230229","display_name":"Gerwyn Morris","orcid":"https://orcid.org/0000-0002-2914-1128","observed_orcids":["https://orcid.org/0000-0002-2914-1128"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gerwyn Morris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017280751","display_name":"Andre Ferrer Carvalho","orcid":"https://orcid.org/0000-0001-5593-2778","observed_orcids":["https://orcid.org/0000-0001-5593-2778"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andr\u00e9 F. Carvalho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064433833","display_name":"George Anderson","orcid":"https://orcid.org/0000-0001-7243-0817","observed_orcids":["https://orcid.org/0000-0001-7243-0817"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George Anderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043160837","display_name":"Piotr Ga\u0142ecki","orcid":"https://orcid.org/0000-0003-2447-5636","observed_orcids":["https://orcid.org/0000-0003-2447-5636"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Piotr Galecki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032880777","display_name":"Michael H. J. Maes","orcid":"https://orcid.org/0000-0002-2012-871X","observed_orcids":["https://orcid.org/0000-0002-2012-871X"]},"institutions":[{"id":"https://openalex.org/I132157203","display_name":"Barwon Health","ror":"https://ror.org/00my0hg66","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I132157203"]},{"id":"https://openalex.org/I149704539","display_name":"Deakin University","ror":"https://ror.org/02czsnj07","country_code":"AU","type":"education","lineage":["https://openalex.org/I149704539"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Maes","raw_affiliation_strings":["IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, Vic, Australia. dr.michaelmaes@hotmail.com","IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, Vic, Australia.,Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, Vic, Australia. dr.michaelmaes@hotmail.com","institution_ids":["https://openalex.org/I132157203","https://openalex.org/I149704539"]},{"raw_affiliation_string":"IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, Vic, Australia.,Australia","institution_ids":["https://openalex.org/I132157203","https://openalex.org/I149704539"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1576,"has_fulltext":false,"cited_by_count":67,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.85714286,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"22","issue":"8","first_page":"963","last_page":"977"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tryptophan-catabolites","display_name":"tryptophan catabolites","score":0.9980000257492065},{"id":"https://openalex.org/keywords/indoleamine-2-3-dioxygenase","display_name":"indoleamine 2,3-dioxygenase","score":0.9089999794960022},{"id":"https://openalex.org/keywords/quinolinic-acid","display_name":"quinolinic acid","score":0.8460000157356262},{"id":"https://openalex.org/keywords/kynurenic-acid","display_name":"kynurenic acid","score":0.996999979019165},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.9179999828338623},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.7789999842643738},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.671999990940094},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.7889999747276306},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.4740000069141388},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.7699999809265137},{"id":"https://openalex.org/keywords/alpha7-nicotinic-acetylcholine-receptor","display_name":"alpha7 nicotinic acetylcholine receptor","score":0.9150000214576721},{"id":"https://openalex.org/keywords/aryl-hydrocarbon-receptor","display_name":"aryl hydrocarbon receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.8289999961853027},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7720000147819519},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/chronic-fatigue-syndrome","display_name":"chronic fatigue syndrome","score":1.0}],"concepts":[{"id":"https://openalex.org/C2777896816","wikidata":"https://www.wikidata.org/wiki/Q411945","display_name":"Quinolinic acid","level":4,"score":0.8866211175918579},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8604292869567871},{"id":"https://openalex.org/C2776841986","wikidata":"https://www.wikidata.org/wiki/Q642217","display_name":"Kynurenic acid","level":4,"score":0.7512407302856445},{"id":"https://openalex.org/C2781012912","wikidata":"https://www.wikidata.org/wiki/Q901117","display_name":"Excitotoxicity","level":4,"score":0.5722033977508545},{"id":"https://openalex.org/C2776710720","wikidata":"https://www.wikidata.org/wiki/Q80417","display_name":"Kynurenine pathway","level":5,"score":0.5713502168655396},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.5388708710670471},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4835736155509949},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.43485522270202637},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4098171591758728},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.36399057507514954},{"id":"https://openalex.org/C2777503454","wikidata":"https://www.wikidata.org/wiki/Q415768","display_name":"Kynurenine","level":4,"score":0.35891181230545044},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3298184871673584},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30260056257247925},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25606316328048706},{"id":"https://openalex.org/C2776706248","wikidata":"https://www.wikidata.org/wiki/Q181003","display_name":"Tryptophan","level":3,"score":0.1758725941181183},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.115180104970932}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007154","descriptor_name":"Immune System Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009498","descriptor_name":"Neurotoxins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014364","descriptor_name":"Tryptophan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015213","descriptor_name":"Neuroimmunomodulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2174/1381612822666151215102420","doi":"https://doi.org/10.2174/1381612822666151215102420","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612822666151215102420","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:26667000","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26667000","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/20892640","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/The_many_neuroprogressive_actions_of_tryptophan_catabolites_TRYCATs_that_may_be_associated_with_the_pathophysiology_of_neuro-immune_disorders/20892640","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/20892640","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/The_many_neuroprogressive_actions_of_tryptophan_catabolites_TRYCATs_that_may_be_associated_with_the_pathophysiology_of_neuro-immune_disorders/20892640","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2407689217","https://openalex.org/W4226084468","https://openalex.org/W4389828851","https://openalex.org/W2921634809","https://openalex.org/W2279906679","https://openalex.org/W4285800327","https://openalex.org/W768875358","https://openalex.org/W2062545296","https://openalex.org/W2055465493","https://openalex.org/W2299985741"],"abstract_inverted_index":{"Many,":[0],"if":[1],"not":[2],"all,":[3],"chronic":[4,13,88,248],"medical,":[5],"neurodegenerative":[6],"and":[7,17,21,48,84,104,131,144,167,170,177,194,217,230,247],"neuroprogressive":[8,85],"illnesses":[9],"are":[10,185],"characterised":[11],"by":[12,121],"immune":[14],"activation,":[15],"oxidative":[16],"nitrosative":[18],"stress":[19],"(O&NS)":[20],"systemic":[22],"inflammation.":[23],"These":[24],"factors,":[25],"notably":[26],"elevated":[27,204],"pro-inflammatory":[28],"cytokines,":[29],"activate":[30],"indoleamine":[31],"2,3-dioxygenase":[32],"(IDO)":[33],"leading":[34],"to":[35,95,172],"an":[36],"upregulated":[37],"tryptophan":[38,43,63],"catabolite":[39],"(TRYCAT)":[40],"pathway":[41,57,93],"of":[42,90,98,101,138,162,175,182,212,238],"degradation":[44,64],"in":[45,49,65,82,125,243],"the":[46,50,55,59,74,91,96,199,210,236,239],"periphery":[47],"brain.":[51],"In":[52,69],"such":[53,109,155],"conditions":[54],"TRYCAT":[56,92,184,241],"becomes":[58],"predominant":[60],"system":[61],"for":[62],"all":[66],"body":[67],"compartments.":[68],"this":[70,183],"paper":[71],"we":[72,234],"review":[73],"pathways":[75,242],"whereby":[76],"TRYCATs":[77,108,154],"may":[78],"play":[79],"a":[80,99,147],"role":[81],"neuro-inflammatory":[83],"disease.":[86],"Thus":[87],"activation":[89],"leads":[94],"production":[97,120],"range":[100],"neuroactive,":[102],"neuroprotective":[103,180,200,226],"neurotoxic":[105,224],"TRYCATs.":[106],"Some":[107],"as":[110,114,146,156,160],"quinolinic":[111],"acid":[112,158,166,206],"act":[113,171],"potent":[115],"neurotoxins":[116],"which":[117],"inhibit":[118],"ATP":[119],"mitochondria,":[122],"provoke":[123],"increases":[124],"O&NS,":[126],"disrupt":[127],"neuron":[128],"glial":[129,139],"communication":[130],"blood":[132],"brain":[133],"barrier":[134],"integrity,":[135],"induce":[136],"apoptosis":[137],"cells,":[140],"directly":[141],"damage":[142],"neurons":[143],"function":[145,159,216],"N-methyl":[148],"D-aspartate":[149],"(NMDA)":[150],"receptor":[151],"agonist.":[152],"Other":[153,220],"kynurenic":[157,205],"antagonists":[161],"NMDA,":[163],"\u03b1-":[164],"amino-3-hydroxy-5-methyl-4-isoxazolepropionic":[165],"kainate":[168],"receptors":[169,197],"regulate":[173],"levels":[174,207],"glutamate":[176],"dopamine.":[178],"The":[179],"functions":[181],"likely":[186],"exercised":[187],"via":[188,228],"engagement":[189],"with":[190],"alpha7":[191],"nicotinic":[192],"acetylcholine":[193],"aryl":[195],"hydrocarbon":[196],"but":[198],"effects":[201],"stemming":[202],"from":[203],"come":[208],"at":[209],"price":[211],"severely":[213],"compromised":[214],"neurocognitive":[215],"emotional":[218],"processing.":[219],"TRYCATS":[221],"also":[222],"possess":[223],"or":[225],"properties":[227],"pro-oxidant":[229],"antioxidant":[231],"effects.":[232],"Here":[233],"discuss":[235],"involvement":[237],"abovementioned":[240],"schizophrenia,":[244],"Alzheimer's":[245],"disease":[246],"fatigue":[249],"syndrome.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2208102967","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":4}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
